IL18 and metabolic disease: Both clinical and experimental studies have demonstrated that adipose tissue macrophages (ATMs) secrete pro-inflammatory cytokines, including interleukin-1β (IL-1β) and IL-18, which are essential factors in the progression of obesity-related metabolic disorders (48).